The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trialsJulian Walter Holch, Volker Heinemann, Ingrid Ricard et al.|European Journal of Cancer|2016Cited by 533
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study groupDominik Paul Modest, Anke Reinacher‐Schick, S. Hegewisch-Becker et al.|Annals of Oncology|2016Cited by 344
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Sylvia Maaß et al.|The Lancet Neurology|2019Cited by 126